Hepatic triglyceride content in individuals with reduced intestinal cholesterol absorption due to variants in Nieman Pick C1-like 1
Open Access
- 29 May 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 54 (2) , 736-737
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesisJournal of Lipid Research, 2010
- Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver diseaseJournal of Gastroenterology, 2010
- Efficacy of ezetimibe for the treatment of non‐alcoholic steatohepatitis: An open‐label, pilot studyHepatology Research, 2010
- Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss DietDiabetes Care, 2010
- Nonalcoholic fatty liver disease and nonalcoholic steatohepatitisHepatology, 2008
- Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genesHuman Molecular Genetics, 2008
- Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levelsProceedings of the National Academy of Sciences, 2006
- The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)Proceedings of the National Academy of Sciences of the United States of America, 2005
- Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general populationAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of EthnicityHepatology, 2004